[
    {
        "id": 6855,
        "drug_name": "PENBRAYA (MenABCWY)",
        "clinical_trial_id": "NCT04440163",
        "has_trial_insight_page": 1,
        "indication": "Meningococcal Vaccine, Adolescents",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-10-20",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/PFE\/news\/165339",
        "note": "FDA approved on October 20, 2023.",
        "company_entity_id": 387,
        "company_ticker": "PFE",
        "company_name": "Pfizer Inc.",
        "company_price": "28.0100",
        "company_change": -0.36,
        "company_percent_change": -1.27,
        "company_optionable": 1,
        "company_number_of_shares": 5646778425,
        "price_change_sparkline": [
            [
                27.08,
                1706677200
            ],
            [
                27.29,
                1706763600
            ],
            [
                26.93,
                1706850000
            ],
            [
                26.57,
                1707109200
            ],
            [
                27.5,
                1707195600
            ],
            [
                27.56,
                1707282000
            ],
            [
                27.57,
                1707368400
            ],
            [
                27.56,
                1707454800
            ],
            [
                27.66,
                1707714000
            ],
            [
                26.97,
                1707800400
            ],
            [
                27.11,
                1707886800
            ],
            [
                27.51,
                1707973200
            ],
            [
                27.62,
                1708059600
            ],
            [
                27.59,
                1708405200
            ],
            [
                27.67,
                1708491600
            ],
            [
                27.55,
                1708578000
            ],
            [
                27.76,
                1708664400
            ],
            [
                27.18,
                1708923600
            ],
            [
                26.89,
                1709010000
            ],
            [
                27.04,
                1709096400
            ],
            [
                26.56,
                1709182800
            ],
            [
                26.59,
                1709269200
            ],
            [
                25.89,
                1709528400
            ],
            [
                26.08,
                1709614800
            ],
            [
                27.19,
                1709701200
            ],
            [
                26.79,
                1709787600
            ],
            [
                27.22,
                1709874000
            ],
            [
                28.37,
                1710129600
            ],
            [
                28.01,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 6429,
        "drug_name": "CABTREO",
        "clinical_trial_id": "NCT04214652",
        "has_trial_insight_page": 0,
        "indication": "Acne vulgaris",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-10-20",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/BHC\/news\/165349",
        "note": "Approved on October 20, 2023.",
        "company_entity_id": 574,
        "company_ticker": "BHC",
        "company_name": "Bausch Health Companies Inc.",
        "company_price": "9.1900",
        "company_change": 0.07,
        "company_percent_change": 0.77,
        "company_optionable": 1,
        "company_number_of_shares": 365411953,
        "price_change_sparkline": [
            [
                7.85,
                1706677200
            ],
            [
                7.98,
                1706763600
            ],
            [
                7.92,
                1706850000
            ],
            [
                7.77,
                1707109200
            ],
            [
                8.13,
                1707195600
            ],
            [
                8.12,
                1707282000
            ],
            [
                8.13,
                1707368400
            ],
            [
                8.21,
                1707454800
            ],
            [
                8.38,
                1707714000
            ],
            [
                8.41,
                1707800400
            ],
            [
                8.43,
                1707886800
            ],
            [
                8.49,
                1707973200
            ],
            [
                8.51,
                1708059600
            ],
            [
                8.6,
                1708405200
            ],
            [
                8.67,
                1708491600
            ],
            [
                9.3,
                1708578000
            ],
            [
                9.18,
                1708664400
            ],
            [
                8.99,
                1708923600
            ],
            [
                9.18,
                1709010000
            ],
            [
                9.2,
                1709096400
            ],
            [
                9.39,
                1709182800
            ],
            [
                9.89,
                1709269200
            ],
            [
                9.58,
                1709528400
            ],
            [
                9.56,
                1709614800
            ],
            [
                9.23,
                1709701200
            ],
            [
                9.28,
                1709787600
            ],
            [
                9.23,
                1709874000
            ],
            [
                9.12,
                1710129600
            ],
            [
                9.19,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 7168,
        "drug_name": "VOXZOGO (Vosoritide)",
        "clinical_trial_id": "NCT04554940",
        "has_trial_insight_page": 1,
        "indication": "Children under age 5 with Achondroplasia",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-10-23",
        "link": "https:\/\/investors.biomarin.com\/2023-10-20-U-S-Food-and-Drug-Administration-Approves-BioMarins-VOXZOGO-R-vosoritide-for-Children-Under-5-Years-with-Achondroplasia",
        "note": "Approved October 23, 2023.",
        "company_entity_id": 69,
        "company_ticker": "BMRN",
        "company_name": "BioMarin Pharmaceutical Inc.",
        "company_price": "85.1800",
        "company_change": -0.8200000000000001,
        "company_percent_change": -0.95,
        "company_optionable": 1,
        "company_number_of_shares": 188675622,
        "price_change_sparkline": [
            [
                88.08,
                1706677200
            ],
            [
                88.74,
                1706763600
            ],
            [
                88.11,
                1706850000
            ],
            [
                87.72,
                1707109200
            ],
            [
                89.8,
                1707195600
            ],
            [
                89.66,
                1707282000
            ],
            [
                88.15,
                1707368400
            ],
            [
                88.46,
                1707454800
            ],
            [
                88.18,
                1707714000
            ],
            [
                86.13,
                1707800400
            ],
            [
                86.01,
                1707886800
            ],
            [
                88.3,
                1707973200
            ],
            [
                88.77,
                1708059600
            ],
            [
                88.67,
                1708405200
            ],
            [
                88.54,
                1708491600
            ],
            [
                89.97,
                1708578000
            ],
            [
                91.24,
                1708664400
            ],
            [
                90.1,
                1708923600
            ],
            [
                90.68,
                1709010000
            ],
            [
                88.4,
                1709096400
            ],
            [
                86.28,
                1709182800
            ],
            [
                87.14,
                1709269200
            ],
            [
                87.72,
                1709528400
            ],
            [
                86.02,
                1709614800
            ],
            [
                86.77,
                1709701200
            ],
            [
                85.89,
                1709787600
            ],
            [
                85.95,
                1709874000
            ],
            [
                86,
                1710129600
            ],
            [
                85.18,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 8199,
        "drug_name": "IL-15 Superagonist N-803 - (QUILT 3.032)",
        "clinical_trial_id": "NCT03022825",
        "has_trial_insight_page": 0,
        "indication": "BCG-Unresponsive Bladder Cancer Carcinoma",
        "label": "BLA Filing",
        "value": "blaFiling",
        "simplified_stage": "phase4",
        "stageid": 12,
        "stage_name": "BLA Filing",
        "date": "2023-10-23",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/IBRX\/news\/165471",
        "note": "BLA Resubmitted to the FDA, noted October 23, 2023.",
        "company_entity_id": 904,
        "company_ticker": "IBRX",
        "company_name": "ImmunityBio Inc.",
        "company_price": "5.0500",
        "company_change": -0.08999999999999997,
        "company_percent_change": -1.75,
        "company_optionable": 1,
        "company_number_of_shares": 667705368,
        "price_change_sparkline": [
            [
                3.36,
                1706677200
            ],
            [
                3.65,
                1706763600
            ],
            [
                4.14,
                1706850000
            ],
            [
                4.04,
                1707109200
            ],
            [
                4.22,
                1707195600
            ],
            [
                4.14,
                1707282000
            ],
            [
                4.31,
                1707368400
            ],
            [
                4.58,
                1707454800
            ],
            [
                4.74,
                1707714000
            ],
            [
                4.23,
                1707800400
            ],
            [
                4.58,
                1707886800
            ],
            [
                4.78,
                1707973200
            ],
            [
                4.85,
                1708059600
            ],
            [
                4.73,
                1708405200
            ],
            [
                4.68,
                1708491600
            ],
            [
                5.24,
                1708578000
            ],
            [
                3.5,
                1708664400
            ],
            [
                4.19,
                1708923600
            ],
            [
                4.59,
                1709010000
            ],
            [
                4.55,
                1709096400
            ],
            [
                4.73,
                1709182800
            ],
            [
                4.71,
                1709269200
            ],
            [
                5.07,
                1709528400
            ],
            [
                4.82,
                1709614800
            ],
            [
                5.08,
                1709701200
            ],
            [
                5.05,
                1709787600
            ],
            [
                5.49,
                1709874000
            ],
            [
                5.14,
                1710129600
            ],
            [
                5.05,
                1710216000
            ]
        ],
        "statuses": [
            {
                "label": "Breakthrough Therapy Designation (BTD)",
                "abbreviation": "BTD",
                "description": "Breakthrough Therapy Designation (BTD)",
                "description_html": "<p>Breakthrough Therapy Designation (BTD)<\/p>\n"
            },
            {
                "label": "Fast Track Designation (FTD)",
                "abbreviation": "FTD",
                "description": "Fast Track Designation (FTD)",
                "description_html": "<p>Fast Track Designation (FTD)<\/p>\n"
            }
        ]
    },
    {
        "id": 10453,
        "drug_name": "AGAMREE (vamorolone)",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Duchenne Muscular Dystrophy (DMD)",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-10-26",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/CPRX\/news\/166187",
        "note": "Approved October 26, 2023.",
        "company_entity_id": 100,
        "company_ticker": "CPRX",
        "company_name": "Catalyst Pharmaceuticals Inc.",
        "company_price": "16.2000",
        "company_change": 0.1,
        "company_percent_change": 0.62,
        "company_optionable": 1,
        "company_number_of_shares": 117863258,
        "price_change_sparkline": [
            [
                14.4,
                1706677200
            ],
            [
                14.43,
                1706763600
            ],
            [
                13.62,
                1706850000
            ],
            [
                13.39,
                1707109200
            ],
            [
                13.75,
                1707195600
            ],
            [
                13.35,
                1707282000
            ],
            [
                13.37,
                1707368400
            ],
            [
                13.64,
                1707454800
            ],
            [
                13.64,
                1707714000
            ],
            [
                13.18,
                1707800400
            ],
            [
                13.48,
                1707886800
            ],
            [
                13.89,
                1707973200
            ],
            [
                14,
                1708059600
            ],
            [
                13.79,
                1708405200
            ],
            [
                13.71,
                1708491600
            ],
            [
                13.9,
                1708578000
            ],
            [
                14.04,
                1708664400
            ],
            [
                14.18,
                1708923600
            ],
            [
                14.35,
                1709010000
            ],
            [
                14.56,
                1709096400
            ],
            [
                16.03,
                1709182800
            ],
            [
                17.01,
                1709269200
            ],
            [
                16.69,
                1709528400
            ],
            [
                16.27,
                1709614800
            ],
            [
                15.86,
                1709701200
            ],
            [
                16.64,
                1709787600
            ],
            [
                16.25,
                1709874000
            ],
            [
                16.1,
                1710129600
            ],
            [
                16.2,
                1710216000
            ]
        ],
        "statuses": [
            {
                "label": "Fast Track Designation (FTD)",
                "abbreviation": "FTD",
                "description": "Fast Track Designation (FTD)",
                "description_html": "<p>Fast Track Designation (FTD)<\/p>\n"
            }
        ]
    },
    {
        "id": 10453,
        "drug_name": "AGAMREE (vamorolone)",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Duchenne Muscular Dystrophy (DMD)",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-10-26",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/CPRX\/news\/166187",
        "note": "Approved October 26, 2023.",
        "company_entity_id": 919,
        "company_ticker": "EWTX",
        "company_name": "Edgewise Therapeutics Inc.",
        "company_price": "17.7200",
        "company_change": 0.97,
        "company_percent_change": 5.79,
        "company_optionable": 1,
        "company_number_of_shares": 93110623,
        "price_change_sparkline": [
            [
                17.83,
                1706677200
            ],
            [
                19.18,
                1706763600
            ],
            [
                18.55,
                1706850000
            ],
            [
                18.76,
                1707109200
            ],
            [
                19.63,
                1707195600
            ],
            [
                19.97,
                1707282000
            ],
            [
                19.81,
                1707368400
            ],
            [
                19.47,
                1707454800
            ],
            [
                18.95,
                1707714000
            ],
            [
                18.91,
                1707800400
            ],
            [
                17.94,
                1707886800
            ],
            [
                18.32,
                1707973200
            ],
            [
                17.37,
                1708059600
            ],
            [
                17.57,
                1708405200
            ],
            [
                17.5,
                1708491600
            ],
            [
                17.37,
                1708578000
            ],
            [
                17.28,
                1708664400
            ],
            [
                17.04,
                1708923600
            ],
            [
                16.85,
                1709010000
            ],
            [
                16.65,
                1709096400
            ],
            [
                16.33,
                1709182800
            ],
            [
                16.69,
                1709269200
            ],
            [
                17,
                1709528400
            ],
            [
                16.97,
                1709614800
            ],
            [
                17,
                1709701200
            ],
            [
                17.74,
                1709787600
            ],
            [
                17.16,
                1709874000
            ],
            [
                16.75,
                1710129600
            ],
            [
                17.72,
                1710216000
            ]
        ],
        "statuses": [
            {
                "label": "Fast Track Designation (FTD)",
                "abbreviation": "FTD",
                "description": "Fast Track Designation (FTD)",
                "description_html": "<p>Fast Track Designation (FTD)<\/p>\n"
            }
        ]
    },
    {
        "id": 7409,
        "drug_name": "LOQTORZI (toripalimab-tpzi) in combination with cisplatin and gemcitabine",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Nasopharyngeal carcinoma (NPC)",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-10-27",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/CHRS\/news\/166363",
        "note": "FDA Approval on October 27, 202",
        "company_entity_id": 89,
        "company_ticker": "CHRS",
        "company_name": "Coherus BioSciences Inc.",
        "company_price": "2.2400",
        "company_change": -0.030000000000000027,
        "company_percent_change": -1.3199999999999998,
        "company_optionable": 1,
        "company_number_of_shares": 111364152,
        "price_change_sparkline": [
            [
                2.15,
                1706677200
            ],
            [
                2.09,
                1706763600
            ],
            [
                2.06,
                1706850000
            ],
            [
                2.02,
                1707109200
            ],
            [
                2.32,
                1707195600
            ],
            [
                2.32,
                1707282000
            ],
            [
                2.38,
                1707368400
            ],
            [
                2.62,
                1707454800
            ],
            [
                2.82,
                1707714000
            ],
            [
                2.56,
                1707800400
            ],
            [
                2.72,
                1707886800
            ],
            [
                2.85,
                1707973200
            ],
            [
                2.76,
                1708059600
            ],
            [
                2.59,
                1708405200
            ],
            [
                2.48,
                1708491600
            ],
            [
                2.47,
                1708578000
            ],
            [
                2.58,
                1708664400
            ],
            [
                2.5,
                1708923600
            ],
            [
                2.62,
                1709010000
            ],
            [
                2.36,
                1709096400
            ],
            [
                2.28,
                1709182800
            ],
            [
                2.41,
                1709269200
            ],
            [
                2.27,
                1709528400
            ],
            [
                2.18,
                1709614800
            ],
            [
                2.21,
                1709701200
            ],
            [
                2.21,
                1709787600
            ],
            [
                2.39,
                1709874000
            ],
            [
                2.27,
                1710129600
            ],
            [
                2.24,
                1710216000
            ]
        ],
        "statuses": [
            {
                "label": "Breakthrough Therapy Designation (BTD)",
                "abbreviation": "BTD",
                "description": "Breakthrough Therapy Designation (BTD)",
                "description_html": "<p>Breakthrough Therapy Designation (BTD)<\/p>\n"
            }
        ]
    },
    {
        "id": 10174,
        "drug_name": "Vabysmo (faricimab-svoa)",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Macular edema due to RVO",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-10-27",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/RHHBY\/news\/166274",
        "note": "Approved October 27, 2023.",
        "company_entity_id": 536,
        "company_ticker": "RHHBY",
        "company_name": "Roche Holding AG ADR",
        "company_price": "35.1500",
        "company_change": 0.54,
        "company_percent_change": 1.56,
        "company_optionable": 0,
        "company_number_of_shares": 6389213336,
        "price_change_sparkline": [
            [
                35.14,
                1706677200
            ],
            [
                34.32,
                1706763600
            ],
            [
                33.95,
                1706850000
            ],
            [
                33.16,
                1707109200
            ],
            [
                33.27,
                1707195600
            ],
            [
                32.55,
                1707282000
            ],
            [
                32.1,
                1707368400
            ],
            [
                32.31,
                1707454800
            ],
            [
                32.6,
                1707714000
            ],
            [
                32.13,
                1707800400
            ],
            [
                32.02,
                1707886800
            ],
            [
                32.1,
                1707973200
            ],
            [
                32.28,
                1708059600
            ],
            [
                32.74,
                1708405200
            ],
            [
                32.91,
                1708491600
            ],
            [
                32.49,
                1708578000
            ],
            [
                32.96,
                1708664400
            ],
            [
                32.52,
                1708923600
            ],
            [
                33.03,
                1709010000
            ],
            [
                32.93,
                1709096400
            ],
            [
                32.73,
                1709182800
            ],
            [
                33.08,
                1709269200
            ],
            [
                32.88,
                1709528400
            ],
            [
                33.15,
                1709614800
            ],
            [
                33.47,
                1709701200
            ],
            [
                33.77,
                1709787600
            ],
            [
                33.9,
                1709874000
            ],
            [
                34.61,
                1710129600
            ],
            [
                35.15,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 6246,
        "drug_name": "VOQUEZNA",
        "clinical_trial_id": "NCT04167670",
        "has_trial_insight_page": 0,
        "indication": "H. pylori",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-10-30",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/PHAT\/news\/166495",
        "note": "Prior Approval Supplement (PAS) for the reformulation of vonoprazan tablets approved October 30, 2023.",
        "company_entity_id": 713,
        "company_ticker": "PHAT",
        "company_name": "Phathom Pharmaceuticals Inc.",
        "company_price": "8.1700",
        "company_change": -0.08999999999999997,
        "company_percent_change": -1.0899999999999999,
        "company_optionable": 1,
        "company_number_of_shares": 58477351,
        "price_change_sparkline": [
            [
                6.7,
                1706677200
            ],
            [
                6.66,
                1706763600
            ],
            [
                6.92,
                1706850000
            ],
            [
                6.68,
                1707109200
            ],
            [
                7.08,
                1707195600
            ],
            [
                7.23,
                1707282000
            ],
            [
                6.975,
                1707368400
            ],
            [
                6.74,
                1707454800
            ],
            [
                6.42,
                1707714000
            ],
            [
                6.21,
                1707800400
            ],
            [
                6.61,
                1707886800
            ],
            [
                6.9,
                1707973200
            ],
            [
                9.29,
                1708059600
            ],
            [
                10.17,
                1708405200
            ],
            [
                10.21,
                1708491600
            ],
            [
                10.47,
                1708578000
            ],
            [
                10.6,
                1708664400
            ],
            [
                9.91,
                1708923600
            ],
            [
                10.15,
                1709010000
            ],
            [
                10.78,
                1709096400
            ],
            [
                10.7,
                1709182800
            ],
            [
                10.69,
                1709269200
            ],
            [
                10.29,
                1709528400
            ],
            [
                9.93,
                1709614800
            ],
            [
                9.73,
                1709701200
            ],
            [
                9.09,
                1709787600
            ],
            [
                8.88,
                1709874000
            ],
            [
                8.26,
                1710129600
            ],
            [
                8.17,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 9184,
        "drug_name": "LOQTORZI (toripalimab-tpzi) with cisplatin and gemcitabine",
        "clinical_trial_id": "NCT03581786",
        "has_trial_insight_page": 0,
        "indication": "1L Metastatic Nasopharyngeal Carcinoma",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-10-30",
        "link": "https:\/\/investors.coherus.com\/news-releases\/news-release-details\/coherus-and-junshi-biosciences-announce-fda-approval-loqtorzitm",
        "note": "Approved October 27, 2023.",
        "company_entity_id": 89,
        "company_ticker": "CHRS",
        "company_name": "Coherus BioSciences Inc.",
        "company_price": "2.2400",
        "company_change": -0.030000000000000027,
        "company_percent_change": -1.3199999999999998,
        "company_optionable": 1,
        "company_number_of_shares": 111364152,
        "price_change_sparkline": [
            [
                2.15,
                1706677200
            ],
            [
                2.09,
                1706763600
            ],
            [
                2.06,
                1706850000
            ],
            [
                2.02,
                1707109200
            ],
            [
                2.32,
                1707195600
            ],
            [
                2.32,
                1707282000
            ],
            [
                2.38,
                1707368400
            ],
            [
                2.62,
                1707454800
            ],
            [
                2.82,
                1707714000
            ],
            [
                2.56,
                1707800400
            ],
            [
                2.72,
                1707886800
            ],
            [
                2.85,
                1707973200
            ],
            [
                2.76,
                1708059600
            ],
            [
                2.59,
                1708405200
            ],
            [
                2.48,
                1708491600
            ],
            [
                2.47,
                1708578000
            ],
            [
                2.58,
                1708664400
            ],
            [
                2.5,
                1708923600
            ],
            [
                2.62,
                1709010000
            ],
            [
                2.36,
                1709096400
            ],
            [
                2.28,
                1709182800
            ],
            [
                2.41,
                1709269200
            ],
            [
                2.27,
                1709528400
            ],
            [
                2.18,
                1709614800
            ],
            [
                2.21,
                1709701200
            ],
            [
                2.21,
                1709787600
            ],
            [
                2.39,
                1709874000
            ],
            [
                2.27,
                1710129600
            ],
            [
                2.24,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 7387,
        "drug_name": "COSENTYX (secukinumab)",
        "clinical_trial_id": "NCT03713632",
        "has_trial_insight_page": 0,
        "indication": "Hidradenitis Suppurativa (HS)",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-10-31",
        "link": "https:\/\/www.novartis.com\/us-en\/news\/media-releases\/fda-approves-novartis-cosentyx-first-new-biologic-treatment-option-hidradenitis-suppurativa-patients-nearly-decade#:~:text=EAST%20HANOVER%2C%20N.J.%2C%20Oct.,suppurativa%20(HS)%20in%20adults.",
        "note": "Approved October 31, 2023.",
        "company_entity_id": 386,
        "company_ticker": "NVS",
        "company_name": "Novartis AG",
        "company_price": "99.7700",
        "company_change": -1.6,
        "company_percent_change": -1.58,
        "company_optionable": 1,
        "company_number_of_shares": 2044033986,
        "price_change_sparkline": [
            [
                99.701426650332,
                1706677200
            ],
            [
                101.493681927897,
                1706763600
            ],
            [
                99.9423211768864,
                1706850000
            ],
            [
                99.701426650332,
                1707109200
            ],
            [
                99.9615927390107,
                1707195600
            ],
            [
                99.6917908692698,
                1707282000
            ],
            [
                97.6682768462129,
                1707368400
            ],
            [
                97.3502960711611,
                1707454800
            ],
            [
                96.8685070180523,
                1707714000
            ],
            [
                95.4520472019125,
                1707800400
            ],
            [
                95.4424114208503,
                1707886800
            ],
            [
                96.0012867224565,
                1707973200
            ],
            [
                96.5408904619384,
                1708059600
            ],
            [
                98.9787430706688,
                1708405200
            ],
            [
                98.824570573674,
                1708491600
            ],
            [
                99.0558293191662,
                1708578000
            ],
            [
                100.115765236006,
                1708664400
            ],
            [
                99.4894394669641,
                1708923600
            ],
            [
                99.3930816563424,
                1709010000
            ],
            [
                98.49695401756,
                1709096400
            ],
            [
                97.2924813847881,
                1709182800
            ],
            [
                98.3427815205652,
                1709269200
            ],
            [
                98.2560594910056,
                1709528400
            ],
            [
                98.3813246448139,
                1709614800
            ],
            [
                98.9016568221714,
                1709701200
            ],
            [
                99.93,
                1709787600
            ],
            [
                100.71,
                1709874000
            ],
            [
                101.37,
                1710129600
            ],
            [
                99.77,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 10129,
        "drug_name": "KEYTRUDA with chemotherapy (gemcitabine and cisplatin - (KEYNOTE-966)",
        "clinical_trial_id": "NCT04003636",
        "has_trial_insight_page": 0,
        "indication": "Biliary Tract Cancer",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-11-01",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/MRK\/news\/166994",
        "note": "Approved November 1, 2023.",
        "company_entity_id": 383,
        "company_ticker": "MRK",
        "company_name": "Merck & Company Inc.",
        "company_price": "122.6600",
        "company_change": -0.10999999999999999,
        "company_percent_change": -0.08999999999999997,
        "company_optionable": 1,
        "company_number_of_shares": 2532643872,
        "price_change_sparkline": [
            [
                120.78,
                1706677200
            ],
            [
                126.38,
                1706763600
            ],
            [
                126.41,
                1706850000
            ],
            [
                126.18,
                1707109200
            ],
            [
                126.88,
                1707195600
            ],
            [
                127.47,
                1707282000
            ],
            [
                126.61,
                1707368400
            ],
            [
                125.45,
                1707454800
            ],
            [
                125.34,
                1707714000
            ],
            [
                125.43,
                1707800400
            ],
            [
                125.82,
                1707886800
            ],
            [
                126.54,
                1707973200
            ],
            [
                127.79,
                1708059600
            ],
            [
                127.37,
                1708405200
            ],
            [
                128.12,
                1708491600
            ],
            [
                129.26,
                1708578000
            ],
            [
                129.45,
                1708664400
            ],
            [
                128.84,
                1708923600
            ],
            [
                129.03,
                1709010000
            ],
            [
                128.19,
                1709096400
            ],
            [
                127.15,
                1709182800
            ],
            [
                126.96,
                1709269200
            ],
            [
                124.05,
                1709528400
            ],
            [
                122.83,
                1709614800
            ],
            [
                123.75,
                1709701200
            ],
            [
                123.99,
                1709787600
            ],
            [
                123.5,
                1709874000
            ],
            [
                122.77,
                1710129600
            ],
            [
                122.66,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 6245,
        "drug_name": "VOQUEZNA (Vonoprazan) - (PHALCON-EE)",
        "clinical_trial_id": "NCT04124926",
        "has_trial_insight_page": 0,
        "indication": "Erosive esophagitis \/ Gastroesophageal reflux disease (GERD)",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-11-01",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/PHAT\/news\/167311",
        "note": "FDA Approved on November 1, 2023.",
        "company_entity_id": 713,
        "company_ticker": "PHAT",
        "company_name": "Phathom Pharmaceuticals Inc.",
        "company_price": "8.1700",
        "company_change": -0.08999999999999997,
        "company_percent_change": -1.0899999999999999,
        "company_optionable": 1,
        "company_number_of_shares": 58477351,
        "price_change_sparkline": [
            [
                6.7,
                1706677200
            ],
            [
                6.66,
                1706763600
            ],
            [
                6.92,
                1706850000
            ],
            [
                6.68,
                1707109200
            ],
            [
                7.08,
                1707195600
            ],
            [
                7.23,
                1707282000
            ],
            [
                6.975,
                1707368400
            ],
            [
                6.74,
                1707454800
            ],
            [
                6.42,
                1707714000
            ],
            [
                6.21,
                1707800400
            ],
            [
                6.61,
                1707886800
            ],
            [
                6.9,
                1707973200
            ],
            [
                9.29,
                1708059600
            ],
            [
                10.17,
                1708405200
            ],
            [
                10.21,
                1708491600
            ],
            [
                10.47,
                1708578000
            ],
            [
                10.6,
                1708664400
            ],
            [
                9.91,
                1708923600
            ],
            [
                10.15,
                1709010000
            ],
            [
                10.78,
                1709096400
            ],
            [
                10.7,
                1709182800
            ],
            [
                10.69,
                1709269200
            ],
            [
                10.29,
                1709528400
            ],
            [
                9.93,
                1709614800
            ],
            [
                9.73,
                1709701200
            ],
            [
                9.09,
                1709787600
            ],
            [
                8.88,
                1709874000
            ],
            [
                8.26,
                1710129600
            ],
            [
                8.17,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 10809,
        "drug_name": "Mydcombi + Optejet device",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Mydriasis (office-based pupil dilation)",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-11-02",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/EYEN\/news\/167362",
        "note": "FDA supplemental approval on November 1, 2023.",
        "company_entity_id": 531,
        "company_ticker": "EYEN",
        "company_name": "Eyenovia Inc.",
        "company_price": "1.6500",
        "company_change": 0.07,
        "company_percent_change": 4.43,
        "company_optionable": 1,
        "company_number_of_shares": 44122225,
        "price_change_sparkline": [
            [
                1.82,
                1706677200
            ],
            [
                1.9,
                1706763600
            ],
            [
                1.81,
                1706850000
            ],
            [
                1.75,
                1707109200
            ],
            [
                1.79,
                1707195600
            ],
            [
                1.765,
                1707282000
            ],
            [
                1.775,
                1707368400
            ],
            [
                1.83,
                1707454800
            ],
            [
                1.91,
                1707714000
            ],
            [
                1.8,
                1707800400
            ],
            [
                1.78,
                1707886800
            ],
            [
                1.76,
                1707973200
            ],
            [
                1.7,
                1708059600
            ],
            [
                1.605,
                1708405200
            ],
            [
                1.59,
                1708491600
            ],
            [
                1.67,
                1708578000
            ],
            [
                1.69,
                1708664400
            ],
            [
                1.98,
                1708923600
            ],
            [
                2.16,
                1709010000
            ],
            [
                2.3,
                1709096400
            ],
            [
                2.165,
                1709182800
            ],
            [
                2.37,
                1709269200
            ],
            [
                2.28,
                1709528400
            ],
            [
                1.76,
                1709614800
            ],
            [
                1.695,
                1709701200
            ],
            [
                1.72,
                1709787600
            ],
            [
                1.58,
                1709874000
            ],
            [
                1.58,
                1710129600
            ],
            [
                1.65,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 5961,
        "drug_name": "FRUZAQLA (fruquintinib)",
        "clinical_trial_id": "NCT04322539",
        "has_trial_insight_page": 1,
        "indication": "Colorectal cancer",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-11-08",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/TAK\/news\/168855",
        "note": "FDA Approved on November 8, 2023.",
        "company_entity_id": 689,
        "company_ticker": "HCM",
        "company_name": "HUTCHMED (China) Limited",
        "company_price": "16.3300",
        "company_change": 1.37,
        "company_percent_change": 9.16,
        "company_optionable": 1,
        "company_number_of_shares": 174251254,
        "price_change_sparkline": [
            [
                12.5,
                1706677200
            ],
            [
                12.93,
                1706763600
            ],
            [
                12.36,
                1706850000
            ],
            [
                12.08,
                1707109200
            ],
            [
                13.51,
                1707195600
            ],
            [
                13.7,
                1707282000
            ],
            [
                13.93,
                1707368400
            ],
            [
                14.01,
                1707454800
            ],
            [
                14.12,
                1707714000
            ],
            [
                14.01,
                1707800400
            ],
            [
                13.53,
                1707886800
            ],
            [
                13.67,
                1707973200
            ],
            [
                14.59,
                1708059600
            ],
            [
                14.41,
                1708405200
            ],
            [
                14.48,
                1708491600
            ],
            [
                15.66,
                1708578000
            ],
            [
                15.72,
                1708664400
            ],
            [
                15.64,
                1708923600
            ],
            [
                15.99,
                1709010000
            ],
            [
                15.21,
                1709096400
            ],
            [
                15.11,
                1709182800
            ],
            [
                15.15,
                1709269200
            ],
            [
                15.12,
                1709528400
            ],
            [
                13.83,
                1709614800
            ],
            [
                14.9,
                1709701200
            ],
            [
                14.52,
                1709787600
            ],
            [
                14.87,
                1709874000
            ],
            [
                14.96,
                1710129600
            ],
            [
                16.33,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 5961,
        "drug_name": "FRUZAQLA (fruquintinib)",
        "clinical_trial_id": "NCT04322539",
        "has_trial_insight_page": 1,
        "indication": "Colorectal cancer",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-11-08",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/TAK\/news\/168855",
        "note": "FDA Approved on November 8, 2023.",
        "company_entity_id": 751,
        "company_ticker": "TAK",
        "company_name": "Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1\/2 of a share of)",
        "company_price": "14.3700",
        "company_change": -0.19999999999999996,
        "company_percent_change": -1.37,
        "company_optionable": 1,
        "company_number_of_shares": 3137776702,
        "price_change_sparkline": [
            [
                14.6,
                1706677200
            ],
            [
                14.38,
                1706763600
            ],
            [
                14.28,
                1706850000
            ],
            [
                13.92,
                1707109200
            ],
            [
                14.16,
                1707195600
            ],
            [
                14.18,
                1707282000
            ],
            [
                14,
                1707368400
            ],
            [
                14.24,
                1707454800
            ],
            [
                14.31,
                1707714000
            ],
            [
                14.34,
                1707800400
            ],
            [
                14.54,
                1707886800
            ],
            [
                14.42,
                1707973200
            ],
            [
                14.62,
                1708059600
            ],
            [
                14.82,
                1708405200
            ],
            [
                14.74,
                1708491600
            ],
            [
                14.64,
                1708578000
            ],
            [
                14.62,
                1708664400
            ],
            [
                14.81,
                1708923600
            ],
            [
                14.84,
                1709010000
            ],
            [
                14.65,
                1709096400
            ],
            [
                14.59,
                1709182800
            ],
            [
                14.56,
                1709269200
            ],
            [
                14.48,
                1709528400
            ],
            [
                14.4,
                1709614800
            ],
            [
                14.69,
                1709701200
            ],
            [
                14.86,
                1709787600
            ],
            [
                14.77,
                1709874000
            ],
            [
                14.57,
                1710129600
            ],
            [
                14.37,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 7347,
        "drug_name": "ADZYNMA (ADAMTS13, recombinant-krhn)",
        "clinical_trial_id": "NCT04683003",
        "has_trial_insight_page": 1,
        "indication": "Congenital thrombotic thrombocytopenic purpura (cTTP)",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-11-09",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/TAK\/news\/169105",
        "note": "FDA Approved on November 9, 2023.",
        "company_entity_id": 751,
        "company_ticker": "TAK",
        "company_name": "Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1\/2 of a share of)",
        "company_price": "14.3700",
        "company_change": -0.19999999999999996,
        "company_percent_change": -1.37,
        "company_optionable": 1,
        "company_number_of_shares": 3137776702,
        "price_change_sparkline": [
            [
                14.6,
                1706677200
            ],
            [
                14.38,
                1706763600
            ],
            [
                14.28,
                1706850000
            ],
            [
                13.92,
                1707109200
            ],
            [
                14.16,
                1707195600
            ],
            [
                14.18,
                1707282000
            ],
            [
                14,
                1707368400
            ],
            [
                14.24,
                1707454800
            ],
            [
                14.31,
                1707714000
            ],
            [
                14.34,
                1707800400
            ],
            [
                14.54,
                1707886800
            ],
            [
                14.42,
                1707973200
            ],
            [
                14.62,
                1708059600
            ],
            [
                14.82,
                1708405200
            ],
            [
                14.74,
                1708491600
            ],
            [
                14.64,
                1708578000
            ],
            [
                14.62,
                1708664400
            ],
            [
                14.81,
                1708923600
            ],
            [
                14.84,
                1709010000
            ],
            [
                14.65,
                1709096400
            ],
            [
                14.59,
                1709182800
            ],
            [
                14.56,
                1709269200
            ],
            [
                14.48,
                1709528400
            ],
            [
                14.4,
                1709614800
            ],
            [
                14.69,
                1709701200
            ],
            [
                14.86,
                1709787600
            ],
            [
                14.77,
                1709874000
            ],
            [
                14.57,
                1710129600
            ],
            [
                14.37,
                1710216000
            ]
        ],
        "statuses": [
            {
                "label": "Fast Track Designation (FTD)",
                "abbreviation": "FTD",
                "description": "Fast Track Designation (FTD)",
                "description_html": "<p>Fast Track Designation (FTD)<\/p>\n"
            },
            {
                "label": "Orphan Drug Designation (ODD)",
                "abbreviation": "ODD",
                "description": "Orphan Drug Designation (ODD)",
                "description_html": "<p>Orphan Drug Designation (ODD)<\/p>\n"
            },
            {
                "label": "Rare Pediatric Disease designation",
                "abbreviation": "RPDD",
                "description": "Rare Pediatric Disease designation (RPDD)",
                "description_html": "<p>Rare Pediatric Disease designation (RPDD)<\/p>\n"
            }
        ]
    },
    {
        "id": 8737,
        "drug_name": "IXCHIQ",
        "clinical_trial_id": "NCT04786444",
        "has_trial_insight_page": 1,
        "indication": "Chikungunya Vaccine",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-11-10",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/VALN\/news\/169245",
        "note": "FDA Approved on November 10, 2023.",
        "company_entity_id": 932,
        "company_ticker": "VALN",
        "company_name": "Valneva SE",
        "company_price": "7.3750",
        "company_change": -0.010000000000000009,
        "company_percent_change": -0.06999999999999995,
        "company_optionable": 0,
        "company_number_of_shares": 69183741,
        "price_change_sparkline": [
            [
                8.15,
                1706677200
            ],
            [
                8.2199,
                1706763600
            ],
            [
                8.09,
                1706850000
            ],
            [
                7.72,
                1707109200
            ],
            [
                8.4182,
                1707195600
            ],
            [
                8.2999,
                1707282000
            ],
            [
                8.5,
                1707368400
            ],
            [
                8.08,
                1707454800
            ],
            [
                8.21,
                1707714000
            ],
            [
                7.91,
                1707800400
            ],
            [
                8.0348,
                1707886800
            ],
            [
                8.33,
                1707973200
            ],
            [
                7.975,
                1708059600
            ],
            [
                7.22,
                1708405200
            ],
            [
                7.25,
                1708491600
            ],
            [
                7.21,
                1708578000
            ],
            [
                7.2001,
                1708664400
            ],
            [
                7.01,
                1708923600
            ],
            [
                7.2334,
                1709010000
            ],
            [
                7.2999,
                1709096400
            ],
            [
                7.1,
                1709182800
            ],
            [
                7.07,
                1709269200
            ],
            [
                6.8,
                1709528400
            ],
            [
                6.67,
                1709614800
            ],
            [
                6.64,
                1709701200
            ],
            [
                6.82,
                1709787600
            ],
            [
                7.22,
                1709874000
            ],
            [
                7.38,
                1710129600
            ],
            [
                7.375,
                1710216000
            ]
        ],
        "statuses": [
            {
                "label": "Breakthrough Therapy Designation (BTD)",
                "abbreviation": "BTD",
                "description": "Breakthrough Therapy Designation (BTD)",
                "description_html": "<p>Breakthrough Therapy Designation (BTD)<\/p>\n"
            },
            {
                "label": "Fast Track Designation (FTD)",
                "abbreviation": "FTD",
                "description": "Fast Track Designation (FTD)",
                "description_html": "<p>Fast Track Designation (FTD)<\/p>\n"
            }
        ]
    },
    {
        "id": 9621,
        "drug_name": "EXPAREL",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Nerve blocker in lower extremity surgeries",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-11-10",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/PCRX\/news\/169253",
        "note": "Expanded label approval announced on November 10, 2023.",
        "company_entity_id": 239,
        "company_ticker": "PCRX",
        "company_name": "Pacira BioSciences Inc.",
        "company_price": "30.5600",
        "company_change": -0.45999999999999996,
        "company_percent_change": -1.48,
        "company_optionable": 1,
        "company_number_of_shares": 46500778,
        "price_change_sparkline": [
            [
                32.59,
                1706677200
            ],
            [
                31.775,
                1706763600
            ],
            [
                30.34,
                1706850000
            ],
            [
                31.14,
                1707109200
            ],
            [
                30.78,
                1707195600
            ],
            [
                28.49,
                1707282000
            ],
            [
                27.7,
                1707368400
            ],
            [
                28.78,
                1707454800
            ],
            [
                30.02,
                1707714000
            ],
            [
                29.21,
                1707800400
            ],
            [
                29.23,
                1707886800
            ],
            [
                29.66,
                1707973200
            ],
            [
                29.08,
                1708059600
            ],
            [
                29.86,
                1708405200
            ],
            [
                29.7,
                1708491600
            ],
            [
                29.97,
                1708578000
            ],
            [
                30.04,
                1708664400
            ],
            [
                29.74,
                1708923600
            ],
            [
                29.85,
                1709010000
            ],
            [
                29.91,
                1709096400
            ],
            [
                29.72,
                1709182800
            ],
            [
                28.86,
                1709269200
            ],
            [
                29.2,
                1709528400
            ],
            [
                29.44,
                1709614800
            ],
            [
                30.11,
                1709701200
            ],
            [
                30.64,
                1709787600
            ],
            [
                31.41,
                1709874000
            ],
            [
                31.02,
                1710129600
            ],
            [
                30.56,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 3467,
        "drug_name": "DEFENCATH (Neutrolin)",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Hemodialysis patients with central venous catheters",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-11-15",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/CRMD\/news\/170383",
        "note": "FDA approval on November 15, 2023.",
        "company_entity_id": 103,
        "company_ticker": "CRMD",
        "company_name": "CorMedix Inc.",
        "company_price": "3.4200",
        "company_change": -0.09999999999999998,
        "company_percent_change": -2.84,
        "company_optionable": 1,
        "company_number_of_shares": 54812042,
        "price_change_sparkline": [
            [
                2.95,
                1706677200
            ],
            [
                3.04,
                1706763600
            ],
            [
                3.1,
                1706850000
            ],
            [
                2.98,
                1707109200
            ],
            [
                2.96,
                1707195600
            ],
            [
                2.94,
                1707282000
            ],
            [
                3.02,
                1707368400
            ],
            [
                3.18,
                1707454800
            ],
            [
                3.29,
                1707714000
            ],
            [
                3.08,
                1707800400
            ],
            [
                3.2,
                1707886800
            ],
            [
                3.27,
                1707973200
            ],
            [
                3.31,
                1708059600
            ],
            [
                3.29,
                1708405200
            ],
            [
                3.25,
                1708491600
            ],
            [
                3.24,
                1708578000
            ],
            [
                3.28,
                1708664400
            ],
            [
                3.31,
                1708923600
            ],
            [
                3.53,
                1709010000
            ],
            [
                3.54,
                1709096400
            ],
            [
                3.54,
                1709182800
            ],
            [
                3.67,
                1709269200
            ],
            [
                3.53,
                1709528400
            ],
            [
                3.55,
                1709614800
            ],
            [
                3.59,
                1709701200
            ],
            [
                3.62,
                1709787600
            ],
            [
                3.68,
                1709874000
            ],
            [
                3.52,
                1710129600
            ],
            [
                3.42,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 5660,
        "drug_name": "Augtyro (repotrectinib)",
        "clinical_trial_id": "NCT03093116",
        "has_trial_insight_page": 0,
        "indication": "Non-small-cell lung cancer (NSCLC) and solid tumors",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-11-15",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/BMY\/news\/170475",
        "note": "https:\/\/www.biopharmcatalyst.com\/company\/BMY\/news\/170475",
        "company_entity_id": 376,
        "company_ticker": "BMY",
        "company_name": "Bristol-Myers Squibb Company",
        "company_price": "54.4000",
        "company_change": 0.04,
        "company_percent_change": 0.07,
        "company_optionable": 1,
        "company_number_of_shares": 2022193411,
        "price_change_sparkline": [
            [
                48.87,
                1706677200
            ],
            [
                48.67,
                1706763600
            ],
            [
                48.71,
                1706850000
            ],
            [
                47.98,
                1707109200
            ],
            [
                49.26,
                1707195600
            ],
            [
                48.64,
                1707282000
            ],
            [
                48.71,
                1707368400
            ],
            [
                49.81,
                1707454800
            ],
            [
                49.75,
                1707714000
            ],
            [
                48.71,
                1707800400
            ],
            [
                48.89,
                1707886800
            ],
            [
                49.44,
                1707973200
            ],
            [
                49.86,
                1708059600
            ],
            [
                49.86,
                1708405200
            ],
            [
                50.91,
                1708491600
            ],
            [
                51.33,
                1708578000
            ],
            [
                51.66,
                1708664400
            ],
            [
                50.52,
                1708923600
            ],
            [
                50.51,
                1709010000
            ],
            [
                50.92,
                1709096400
            ],
            [
                50.75,
                1709182800
            ],
            [
                50.89,
                1709269200
            ],
            [
                50.92,
                1709528400
            ],
            [
                51.82,
                1709614800
            ],
            [
                53.38,
                1709701200
            ],
            [
                53.28,
                1709787600
            ],
            [
                53.79,
                1709874000
            ],
            [
                54.36,
                1710129600
            ],
            [
                54.4,
                1710216000
            ]
        ],
        "statuses": [
            {
                "label": "Breakthrough Therapy Designation (BTD)",
                "abbreviation": "BTD",
                "description": "Breakthrough Therapy Designation (BTD)",
                "description_html": "<p>Breakthrough Therapy Designation (BTD)<\/p>\n"
            }
        ]
    },
    {
        "id": 5660,
        "drug_name": "Augtyro (repotrectinib)",
        "clinical_trial_id": "NCT03093116",
        "has_trial_insight_page": 0,
        "indication": "Non-small-cell lung cancer (NSCLC) and solid tumors",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-11-15",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/BMY\/news\/170475",
        "note": "https:\/\/www.biopharmcatalyst.com\/company\/BMY\/news\/170475",
        "company_entity_id": 484,
        "company_ticker": "ZLAB",
        "company_name": "Zai Lab Limited",
        "company_price": "19.5400",
        "company_change": -0.47,
        "company_percent_change": -2.35,
        "company_optionable": 1,
        "company_number_of_shares": 99208743,
        "price_change_sparkline": [
            [
                21.57,
                1706677200
            ],
            [
                22.51,
                1706763600
            ],
            [
                22.5,
                1706850000
            ],
            [
                22.12,
                1707109200
            ],
            [
                21.61,
                1707195600
            ],
            [
                19.66,
                1707282000
            ],
            [
                19.605,
                1707368400
            ],
            [
                18.68,
                1707454800
            ],
            [
                18.21,
                1707714000
            ],
            [
                17.73,
                1707800400
            ],
            [
                19.39,
                1707886800
            ],
            [
                19.89,
                1707973200
            ],
            [
                20.64,
                1708059600
            ],
            [
                19.24,
                1708405200
            ],
            [
                19.91,
                1708491600
            ],
            [
                20.08,
                1708578000
            ],
            [
                19.94,
                1708664400
            ],
            [
                20.99,
                1708923600
            ],
            [
                22.49,
                1709010000
            ],
            [
                20.8,
                1709096400
            ],
            [
                20.98,
                1709182800
            ],
            [
                21.1,
                1709269200
            ],
            [
                20.42,
                1709528400
            ],
            [
                18.91,
                1709614800
            ],
            [
                19.8,
                1709701200
            ],
            [
                19.16,
                1709787600
            ],
            [
                18.91,
                1709874000
            ],
            [
                20.01,
                1710129600
            ],
            [
                19.54,
                1710216000
            ]
        ],
        "statuses": [
            {
                "label": "Breakthrough Therapy Designation (BTD)",
                "abbreviation": "BTD",
                "description": "Breakthrough Therapy Designation (BTD)",
                "description_html": "<p>Breakthrough Therapy Designation (BTD)<\/p>\n"
            }
        ]
    },
    {
        "id": 9269,
        "drug_name": "XTANDI (enzalutamide)",
        "clinical_trial_id": "NCT02319837",
        "has_trial_insight_page": 0,
        "indication": "Nonmetastatic Prostate Cancer (nmCSPC)",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-11-16",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/PFE\/news\/170769",
        "note": "Approved November 16, 2023.",
        "company_entity_id": 387,
        "company_ticker": "PFE",
        "company_name": "Pfizer Inc.",
        "company_price": "28.0100",
        "company_change": -0.36,
        "company_percent_change": -1.27,
        "company_optionable": 1,
        "company_number_of_shares": 5646778425,
        "price_change_sparkline": [
            [
                27.08,
                1706677200
            ],
            [
                27.29,
                1706763600
            ],
            [
                26.93,
                1706850000
            ],
            [
                26.57,
                1707109200
            ],
            [
                27.5,
                1707195600
            ],
            [
                27.56,
                1707282000
            ],
            [
                27.57,
                1707368400
            ],
            [
                27.56,
                1707454800
            ],
            [
                27.66,
                1707714000
            ],
            [
                26.97,
                1707800400
            ],
            [
                27.11,
                1707886800
            ],
            [
                27.51,
                1707973200
            ],
            [
                27.62,
                1708059600
            ],
            [
                27.59,
                1708405200
            ],
            [
                27.67,
                1708491600
            ],
            [
                27.55,
                1708578000
            ],
            [
                27.76,
                1708664400
            ],
            [
                27.18,
                1708923600
            ],
            [
                26.89,
                1709010000
            ],
            [
                27.04,
                1709096400
            ],
            [
                26.56,
                1709182800
            ],
            [
                26.59,
                1709269200
            ],
            [
                25.89,
                1709528400
            ],
            [
                26.08,
                1709614800
            ],
            [
                27.19,
                1709701200
            ],
            [
                26.79,
                1709787600
            ],
            [
                27.22,
                1709874000
            ],
            [
                28.37,
                1710129600
            ],
            [
                28.01,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 9269,
        "drug_name": "XTANDI (enzalutamide)",
        "clinical_trial_id": "NCT02319837",
        "has_trial_insight_page": 0,
        "indication": "Nonmetastatic Prostate Cancer (nmCSPC)",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-11-16",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/PFE\/news\/170769",
        "note": "Approved November 16, 2023.",
        "company_entity_id": 2240,
        "company_ticker": "ALPMY",
        "company_name": "Astellas Pharma Inc. ADR",
        "company_price": "10.7600",
        "company_change": -0.13,
        "company_percent_change": -1.19,
        "company_optionable": 0,
        "company_number_of_shares": 1808873137,
        "price_change_sparkline": [
            [
                11.6,
                1706677200
            ],
            [
                11.55,
                1706763600
            ],
            [
                11.35,
                1706850000
            ],
            [
                11,
                1707109200
            ],
            [
                10.89,
                1707195600
            ],
            [
                10.92,
                1707282000
            ],
            [
                10.73,
                1707368400
            ],
            [
                10.79,
                1707454800
            ],
            [
                10.82,
                1707714000
            ],
            [
                10.89,
                1707800400
            ],
            [
                11.075,
                1707886800
            ],
            [
                11.05,
                1707973200
            ],
            [
                11.1,
                1708059600
            ],
            [
                11.14,
                1708405200
            ],
            [
                11.12,
                1708491600
            ],
            [
                10.96,
                1708578000
            ],
            [
                10.99,
                1708664400
            ],
            [
                11.03,
                1708923600
            ],
            [
                10.99,
                1709010000
            ],
            [
                10.98,
                1709096400
            ],
            [
                10.93,
                1709182800
            ],
            [
                11.15,
                1709269200
            ],
            [
                11.08,
                1709528400
            ],
            [
                10.8,
                1709614800
            ],
            [
                10.81,
                1709701200
            ],
            [
                10.75,
                1709787600
            ],
            [
                10.62,
                1709874000
            ],
            [
                10.89,
                1710129600
            ],
            [
                10.76,
                1710216000
            ]
        ],
        "statuses": []
    }
]